Show simple item record

dc.contributor.authorWorld Health Organization
dc.coverage.spatialGenevaen_US
dc.date.accessioned2017-07-14T12:56:05Z
dc.date.available2017-07-14T12:56:05Z
dc.date.issued2017
dc.identifier.govdocWHO/HIV/2017.20
dc.identifier.urihttps://apps.who.int/iris/handle/10665/255888
dc.description8 p.en_US
dc.language.isoenen_US
dc.publisherWorld Health Organizationen_US
dc.rightsCC BY-NC-SA 3.0 IGOen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/3.0/igoen_US
dc.subject.meshHIVen_US
dc.subject.meshHIV Infectionsen_US
dc.subject.meshAnti-Retroviral Agentsen_US
dc.subject.meshAnti-HIV Agentsen_US
dc.subject.meshClinical Medicineen_US
dc.titleHIV treatment: transition to new antiretrovirals in HIV programmes: policy briefen_US
dc.typeTechnical documentsen_US
dc.rights.holderWorld Health Organizationen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record